QY Research has published the new industry research of the “Global Acne Vulgaris Treatment Market Size and Forecast 2025” The report focuses on Global major leading players with information such as company profiles, product picture, future road map, opportunities and investment.

City of industry, CA -- (SBWire) -- 06/19/2018 --This report studies the global Acne Vulgaris Treatment market status and forecast, categorizes the global Acne Vulgaris Treatment market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The global Acne Vulgaris Treatment market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major manufacturers covered in this report

Common Pharma Inc

Cutanea Life Sciences Inc

Dermira Inc

ELORAC Inc

Ensol Biosciences Inc

Foamix Pharmaceuticals Ltd

Galderma SA

GlaxoSmithKline Plc

Helix BioMedix Inc

Hovione FarmaCiencia SA

Lee's Pharmaceutical Holdings Ltd

LEO Pharma A/S

Novabiotics Ltd

Novan Inc

Novartis AG

Paratek Pharmaceuticals Inc

Pfizer Inc

Phosphagenics Ltd

Request Sample Copy of the Report @ https://www.qyresearch.com/sample-form/form/247404/global-acne-vulgaris-treatment-market

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.